Type i interferon score is associated with the severity and poor prognosis in anti-mda5 antibody-positive dermatomyositis patients

HIGHLIGHTS

• who: Jinjing Qian and collaborators from the Fudan University, China have published the paper: Type I interferon score is associated with the severity and poor prognosis in anti-MDA5 antibody-positive dermatomyositis patients, in the Journal: (JOURNAL)
• what: The authors propose that an IFN-I score of >4.9 could be useful to predict outcomes and assess treatment Frontiers in Immunology efficacy, especially in patients treated with targeted synthetic diseasemodifying antirheumatic drugs, thereby addressing a previously unfulfilled need.
• how: The authors examined the correlations of the IFN-I score with the laboratory findings . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.